安德罗格里斯·帕尼库拉塔 (Andrographis paniculata) 对病毒标的治疗潜力 - - 一个计算洞察力
Rashmi Sahu1, Rajan Mariappan2, Awanish Kumar3
1Department of Kaumarabhritya, Ayurinformatics Laboratory, All India Institute of Ayurveda, New Delhi, India.
In silico pharmacology
|September 15, 2025
概括
来自Andrographis paniculata的天然化合物显示出治疗麻疹 (MPXV) 的希望. 计算研究确定了andrographolide,luteolin和andrographidin-A作为潜在的治疗候选人对抗水病毒.
科学领域:
- 病毒学 病毒学
- 计算化学的计算化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 麻疹 (MPXV) 是一个全球性的健康威胁,人类的传播正在增加.
- 有限的抗病毒治疗需要探索替代疗法.
- 安德罗格拉菲斯 (Andrographis paniculata) 是一种具有已知的抗微生物和抗病毒功能的植物.
研究的目的:
- 使用计算方法调查Andrographis paniculata生物活性化合物的潜力,以对抗麻病毒的点.
- 为了识别具有强大的结合亲和力与病毒蛋白的特定化合物.
主要方法:
- 从蛋白质数据库中获得了病毒蛋白质结构 (4E90,8B07,8C9K,8IZT,8J8G).
- 使用施罗丁格套件进行分子动态模拟.
- 进行了轨迹分析,以评估联结蛋白复合体的稳定性和结合亲和力.
主要成果:
- 安德罗格拉福利德,卢托林和安德罗格拉菲丁-A与病毒病毒标表现出强烈的结合相互作用.
- 形成了稳定的蛋白质 - 配体复合体,表明有利的结合.
- 有利的热力学形状支持了这些化合物的治疗潜力.
结论:
- 来自Andrographis paniculata的生物活性化合物,包括andrographolide,luteolin和andrographidin-A,显示出作为治疗水的治疗剂的巨大潜力.
- 计算方法成功地确定了有前途的天然化合物,用于进一步开发针对MPXV的药物.
相关概念视频
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


